EUVIMEDEUVIMED entdecken
Crossref

Reverse-Engineering Drug-Release Kinetics from Dissolution Profiles with Machine Learning

Sergio Sánchez-Herrero, Joaquin Herrerias-Lopez-De-Heredia, Laura Calvet, Angel A. Juan

Pharmaceutical Sciences · 31.07.2026 · 32 (3) · 394-404

DOI: 10.34172/ps.43408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 31.07.2026. Verfasst von Sergio Sánchez-Herrero und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dissolution is commonly modeled forward from formulation inputs. We propose an inverse-learning framework where machine learning (ML) infers mechanistically interpretable release-kinetic parameters from dissolution profiles and relates them to formulation and pharmacokinetic (PK) descriptors within Quality by Design (QbD).

Methods

An in silico dataset of release profiles was generated using six kinetic models (zero-order, first-order, Higuchi, Hixson–Crowell, Korsmeyer–Peppas and Weibull). Each profile was fitted to all candidate models to select the best mechanism and estimate its parameters. ML regressors (tree-based ensembles and artificial neural networks) were trained using full time series and engineered summaries (e.g., lag time, fractional release at 2/6/12 h and AUC0–24); PK features (e.g., Tmax, Cmax, CL, Vc) were incorporated when applicable. Performance was evaluated by cross-validation and external tests using R² and error metrics, and interpretability was assessed with SHAP.

Results

Gradient boosting performed best for simpler kinetics (zero/first/Higuchi/Hixson–Crowell; R²≈0.99; AFE/AAFE≈1.00–1.01). For complex kinetics, neural networks were best for Korsmeyer–Peppas (R²=0.89), and boosting remained strong for Weibull. SHAP highlighted AUC0–24, Tmax and Cmax as dominant predictors. External experimental profiles showed good agreement by visual comparison.

Conclusion

Inverse learning can recover mechanistically meaningful release parameters from dissolution data and connect them to formulation and PK descriptors, supporting faster and more transparent modified-release design under QbD.

Zitieren

APA

Sánchez-Herrero, S., Herrerias-Lopez-De-Heredia, J., Calvet, L., & Juan, A. A. (2026). Reverse-Engineering Drug-Release Kinetics from Dissolution Profiles with Machine Learning. Pharmaceutical Sciences, 32(3), 394-404. https://doi.org/10.34172/ps.43408

Vancouver

Sánchez-Herrero S, Herrerias-Lopez-De-Heredia J, Calvet L, Juan AA. Reverse-Engineering Drug-Release Kinetics from Dissolution Profiles with Machine Learning. Pharmaceutical Sciences. 2026;32(3):394-404. doi:10.34172/ps.43408

BibTeX
@article{SnchezHerrero2026,
  author = {Sánchez-Herrero, Sergio and Herrerias-Lopez-De-Heredia, Joaquin and Calvet, Laura and Juan, Angel A.},
  title = {Reverse-Engineering Drug-Release Kinetics from Dissolution Profiles with Machine Learning},
  journal = {Pharmaceutical Sciences},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {394--404},
  doi = {10.34172/ps.43408}
}
Kostenlos starten →